People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pelage Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $150.7M | $901.6M | 2023 |
Daniel Gil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Gil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cathy Edward Friedman | 1 | 1 |
| Nathan Edward Wheeler | 1 | 1 |
| William Edward Lowry | 1 | 1 |
| Christina Edward Weng | 1 | 1 |
| Richard Edward Heyman | 1 | 1 |
| Heather Edward Christofk | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.